AYTU BIOPHARMA, INC Current Liabilities
AYTU BIOPHARMA, INC (AYTU) had Current Liabilities of $54.66 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-09-22
- 2026-06-30: Liabilities, Current $54.66M.
- 2026-03-31: Liabilities, Current $59.97M.
- 2025-12-31: Liabilities, Current $65.56M.
- 2025-09-30: Liabilities, Current $65.99M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $54.66M 10-K · filed 2026-09-22 | |
| 2026-03-31 | $59.97M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $65.56M 10-Q · filed 2026-02-03 | |
| 2025-09-30 | $65.99M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $63.06M 10-K · filed 2026-09-22 | |
| 2025-03-31 | $70.71M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $64.05M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $61.25M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $62.23M 10-K · filed 2025-09-23 | |
| 2024-03-31 | $83.69M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $64.19M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $65.46M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $69.02M 10-K · filed 2024-09-26 | |
| 2023-03-31 | $85.42M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $67.15M 10-Q · filed 2023-02-21 | |
| 2022-09-30 | $73.20M 10-Q/A · filed 2023-02-21 | |
| 2022-06-30 | $64.44M 10-K · filed 2023-10-12 | |
| 2022-03-31 | $80.36M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $100.57M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $98.00M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $109.44M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $83.68M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $25.81M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $21.51M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $28.76M 10-K · filed 2021-09-28 | $28.31M 10-K · filed 2020-10-06 |
| 2020-03-31 | $42.03M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $15.95M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $6.10M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $5.37M 10-K · filed 2020-10-06 | |
| 2019-03-31 | $4.50M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $4.66M 10-Q · filed 2019-05-14 | |
| 2018-09-30 | $3.59M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $3.39M 10-K · filed 2019-09-26 | |
| 2018-03-31 | $4.34M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $4.80M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $3.51M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.61M 10-K · filed 2018-09-06 | |
| 2017-03-31 | $3.35M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $6.97M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $8.73M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $10.10M 10-K · filed 2017-08-31 | |
| 2016-03-31 | $3.21M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $2.80M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $1.78M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $1.48M 10-K · filed 2016-09-01 | $1.48M 10-K · filed 2015-09-28 |
| 2015-03-31 | $9.20M 10-Q · filed 2015-05-19 | |
| 2015-02-28 | $60.90K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | $55.24K 10-Q · filed 2015-01-12 | |
| 2014-08-31 | $50.50K 10-Q · filed 2015-04-15 | |
| 2014-06-30 | $6.09M 10-K · filed 2015-09-28 | $6.09M 10-Q · filed 2015-05-19 |
| 2014-05-31 | $49.54K 10-Q · filed 2014-07-10 | |
| 2014-02-28 | $153.45K 10-Q · filed 2014-04-11 | |
| 2013-11-30 | $133.39K 10-Q · filed 2014-01-10 | |
| 2013-08-31 | $120.53K 10-K · filed 2014-11-26 | |
| 2013-05-31 | $115.45K 10-Q · filed 2013-06-28 | |
| 2013-02-28 | $107.95K 10-Q · filed 2013-04-15 | |
| 2012-11-30 | $94.10K 10-Q · filed 2013-01-14 | |
| 2012-08-31 | $82.36K 10-K · filed 2014-11-26 | |
| 2012-05-31 | $68.96K 10-Q · filed 2012-06-26 | |
| 2012-02-29 | $65.74K 10-Q · filed 2012-04-12 | |
| 2011-11-30 | $66.44K 10-Q · filed 2011-12-23 | |
| 2011-08-31 | $58.43K 10-K · filed 2012-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |